ApoB

Circ Res. 2019 May 10;124(10):1425-1427. doi: 10.1161/CIRCRESAHA.119.315019.
No abstract available

Keywords: apoB; atherosclerosis; cardiovascular disease; cholesterol; risk; triglycerides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyl Coenzyme A / antagonists & inhibitors
  • Apolipoprotein B-100 / blood*
  • Apolipoprotein B-100 / chemistry
  • Atherosclerosis / blood
  • Atherosclerosis / etiology
  • Atherosclerosis / prevention & control
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Cardiovascular Physiological Phenomena
  • Cholesterol Ester Transfer Proteins / antagonists & inhibitors
  • Cholesterol, HDL / blood
  • Cholesterol, HDL / chemistry
  • Cholesterol, LDL / blood
  • Cholesterol, LDL / chemistry
  • Chylomicrons / chemistry
  • Evidence-Based Medicine
  • Humans
  • Lipoproteins, VLDL / chemistry
  • Molecular Mimicry
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Triglycerides / blood
  • Triglycerides / chemistry

Substances

  • APOB protein, human
  • Acyl Coenzyme A
  • Apolipoprotein B-100
  • Biomarkers
  • CETP protein, human
  • Cholesterol Ester Transfer Proteins
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Chylomicrons
  • Lipoproteins, VLDL
  • Triglycerides
  • 3-hydroxy-3-methylglutaryl-coenzyme A